PUMA BIOTECHNOLOGY, INC. Prepaid Expense and Other Assets, Current
PUMA BIOTECHNOLOGY, INC. (PBYI) had Prepaid Expense and Other Assets, Current of $11.28 million as of 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2021-08-05
- 2021-06-30: Prepaid Expense and Other Assets, Current $11.28M.
- 2021-03-31: Prepaid Expense and Other Assets, Current $11.59M.
- 2020-12-31: Prepaid Expense and Other Assets, Current $11.26M.
- 2020-09-30: Prepaid Expense and Other Assets, Current $8.03M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2021-06-30 | $11.28M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $11.59M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $11.26M 10-Q · filed 2021-08-05 | |
| 2020-09-30 | $8.03M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $12.60M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $13.94M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $13.26M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $9.99M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $11.01M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $11.98M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $12.40M 10-K · filed 2020-02-28 | |
| 2018-09-30 | $12.38M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $11.73M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $13.58M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $13.00M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $9.28M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $9.15M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $10.65M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $7.00M 10-K · filed 2018-03-09 | |
| 2016-09-30 | $7.29M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $8.78M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $8.14M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $7.66M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $6.89M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $5.42M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $6.36M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $6.29M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $4.48M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $3.49M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $2.25M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $2.63M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $3.64M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $1.14M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $2.15M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $952.00K 10-K · filed 2014-03-03 | |
| 2012-09-30 | $769.88K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $825.97K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $537.60K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $281.00K 10-K · filed 2013-04-01 | $281.10K 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |